Goldman Sachs
YCBD icon

Goldman Sachs’s cbdMD YCBD Stock Holding History

Goldman Sachs’s Portfolio YCBD Stock Details YCBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-103
Closed -$7.24K – 6116
2023
Q1 		$7.24K Hold
103
– – ﹤0.01% 5768
2022
Q4 		$8.42K Hold
103
– – ﹤0.01% 5765
2022
Q3 		$9K Hold
103
– – ﹤0.01% 6037
2022
Q2 		$16K Hold
103
– – ﹤0.01% 6207
2022
Q1 		$39K Sell
103
-1
-1% -$338 ﹤0.01% 6311
2021
Q4 		$40K Hold
104
– – ﹤0.01% 6300
2021
Q3 		$77K Buy
104
+30
+41% +$25.1K ﹤0.01% 5961
2021
Q2 		$77K Hold
74
– – ﹤0.01% 6008
2021
Q1 		$110K Buy
74
+36
+95% +$52.3K ﹤0.01% 5818
2020
Q4 		$40K Buy
38
+2
+6% +$1.82K ﹤0.01% 5402
2020
Q3 		$26K Sell
36
-7
-16% -$6.68K ﹤0.01% 5239
2020
Q2 		$30K Sell
43
-41
-49% -$18.4K ﹤0.01% 5107
2020
Q1 		$28K Buy
84
+55
+190% +$21.7K ﹤0.01% 5101
2019
Q4 		$24K Sell
29
-178
-86% -$214K ﹤0.01% 5168
2019
Q3 		$294K Buy
+207
New +$332K ﹤0.01% 4696
2018
Q1 		– Sell
-31
Closed -$49K – 6458
2017
Q4 		$49K Buy
+31
New +$53.2K ﹤0.01% 5940

Other funds holding YCBD

AI
AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return
SL
Sentinus LLC Oak Brook, Illinois $1.11B AUM 17.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Goldman Sachs's YCBD Position: Q2 2023 in Review

Goldman Sachs sold out of cbdMD (YCBD) in Q2 2023, closing a stake of 103 shares — an estimated $7.24K sold.

Goldman Sachs first reported a position in YCBD in Q4 2017 and held it in 16 quarters. The position peaked at $294K in Q3 2019. 20 funds tracked by Wall St. Rank hold YCBD as of Q2 2023.

  • Goldman Sachs reported no remaining cbdMD position as of Q2 2023 after selling out during the quarter.
  • Goldman Sachs sold 103 cbdMD shares in Q2 2023, an estimated $7.24K.
  • Goldman Sachs first reported a position in cbdMD in Q4 2017 and held it in 16 quarters.
  • Goldman Sachs's cbdMD position peaked at $294K in Q3 2019.
  • 20 funds tracked by Wall St. Rank held cbdMD as of Q2 2023.

Based on Goldman Sachs's 13F filing for Q2 2023, filed 15 Aug 2023.